Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 109Neoplasms 99Lung Neoplasms 60Colorectal Neoplasms 45Prostatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 39Pancreatic Neoplasms 33Melanoma 31Head and Neck Neoplasms 27Neoplastic Cells, Circulating 25Ovarian Neoplasms 24Uterine Cervical Neoplasms 20Sarcoma 19Multiple Myeloma 19Glioma 19Colonic Neoplasms 19Carcinoma, Hepatocellular 17Leukemia, Myeloid, Acute 16Neoplasm Metastasis 15Squamous Cell Carcinoma of Head and Neck 14Lymphoma 14Glioblastoma 14Esophageal Neoplasms 14Endometrial Neoplasms 14Leukemia 12Kidney Neoplasms 11Hematologic Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11Myelodysplastic Syndromes 10

Interventions

siltuximab 4fludarabine 3Cyclophosphamide 3fludarabine phosphate 2Interleukin 1 Receptor Antagonist Protein 2AP 1903 reagent 2tocilizumab 1talquetamab 1axicabtagene ciloleucel 1Neuropsychological Tests 1Metoprolol 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Infliximab 1Etanercept 1Dexamethasone 1Contrast Media 1Calcium Dobesilate 1Blood Specimen Collection 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cytokine Release Syndrome × Blood Specimen Collection × Clear all
NCT03557749 2023-08-21

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Masonic Cancer Center, University of Minnesota

Terminated
210 enrolled

Cytokine Release Syndrome, Bronchiolitis Obliterans Syndrome, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡